During the past decade, SCIderm GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SCIderm GmbH" #1 sponsor was "LEO Pharma" with 3 trials, followed by "Amgen" with 1 trials sponsored, "Forward-Pharma GmbH" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Janssen-Cilag G.m.b.H" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

According to Clinical.Site data, the most researched conditions in "SCIderm GmbH" are "Psoriasis" (3 trials), "Actinic Keratosis" (2 trials), "Psoriasis Vulgaris" (2 trials), "Atopic Dermatitis" (1 trials) and "Blister" (1 trials). Many other conditions were trialed in "SCIderm GmbH" in a lesser frequency.

Most popular intervention types in "SCIderm GmbH" are "Drug" (9 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Guselkumab" (2 trials), "Apremilast" (1 trials), "Brodalumab" (1 trials) and "Diclofenac" (1 trials). Other intervention names were less common.

The vast majority of trials in "SCIderm GmbH" are 11 trials for "All" genders.

Currently, there are NaN active trials in "SCIderm GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in SCIderm GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SCIderm GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".